WallStreetZenWallStreetZen

NYSE: AVNS
Avanos Medical Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Avanos Medical revenue was $687.80M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $179.6M, up 5.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVNS annual revenue was $687.8M, with 2.2% growth year-over-year.

AVNS past revenue growth

How has AVNS's revenue growth performed historically?

Company
2.15%
Industry
10.59%
Market
20.87%
AVNS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AVNS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AVNS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AVNS revenue history

Current Revenue
$687.8M
Current Earnings
-$392.1M
Current Profit Margin
-57%

Be the first to know when AVNS announces revenue.

AVNS Revenue History By Year

AVNS Yearly RevenueAVNS RevenueAVNS ChangeAVNS Revenue Growth
2024-12-31$687.80M$14.50M+2.15%
2023-12-31$673.30M-$10.80M-1.58%
2022-12-31$684.10M$97.10M+16.54%
2021-12-31$587.00M-$127.80M-17.88%
2020-12-31$714.80M$17.20M+2.47%
2019-12-31$697.60M$45.30M+6.94%
2018-12-31$652.30M$40.70M+6.65%
2017-12-31$611.60M$45.40M+8.02%
2016-12-31$566.20M$57.20M+11.24%
2015-12-31$509.00M-$1.16B-69.56%
2014-12-31$1.67B-$5.40M-0.32%
2013-12-31$1.68B-$6.50M-0.39%
2012-12-31$1.68B$24.10M+1.45%
2011-12-31$1.66BN/AN/A

1 of 1

Avanos Medical Revenue FAQ

What was AVNS's revenue last quarter?

On Invalid Date, Avanos Medical (NYSE: AVNS) reported Q4 2024 revenue of $179.60 million up 3.64% year over year. In the same quarter last year, Avanos Medical's revenue was $173.30 million.

What was Avanos Medical's revenue in 2024?

Avanos Medical's annual revenue for the twelve months ending Dec 31, 2024 was $687.80 million, a 2.15% increase year over year.

How much does Avanos Medical make in a day?

Based on Avanos Medical annual revenue for the past five years, AVNS makes an average of $1,833,972.60 per day.

What was Avanos Medical's annual revenue growth in the past year?

As of Q2 2025, Avanos Medical's revenue has grown 2.15% year over year. This is 8.43 percentage points lower than the US Medical Devices industry revenue growth rate of 10.59%. Avanos Medical's revenue in the past year totaled $687.80 million.

How much does Avanos Medical make in a year?

Avanos Medical's revenue by year for the past five years is:
  • Avanos Medical's revenue for the twelve months ending Dec 31, 2024 was $687.80 million, a 2.15% increase year over year.
  • Avanos Medical's annual revenue for Dec 31, 2023 was $673.30 million, a 1.58% decrease from 2022.
  • Avanos Medical's annual revenue for 2022 was $684.10 million, a 16.54% increase from 2021.
  • Avanos Medical's annual revenue for 2021 was $587.00 million, a 17.88% decrease from 2020.
  • Avanos Medical's annual revenue for 2020 was $714.80 million, a 2.47% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.